Form 4 for VOR Vor Biopharma Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-014923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | VOR | ANG ROBERT | Pres, CEO, Dir | F - Tax | $5.51 | -12.7K | 700.7K | -2% | -$69.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 12,657 | $5.51 | 700,665 | D | — | — | (F1) Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs"). |